Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Risks factors

This chapter outlines the major known risk factors for TIA and stroke. Knowledge of these risk factors is necessary in order to understand the aetiology of TIA and stroke, to predict risk and to develop effective preventive strategies. [Pg.16]

There are many more data on risk factors for acute coronary events than for ischemic stroke (Bhatia and Rothwell 2005) because of more intensive investigation in routine clinical practice and because heart disease receives much higher levels of research funding than stroke (Rothwell 2001 Pendlebury 2007). [Pg.16]

Age is the strongest risk factor for ischemic stroke of all subtypes and for primary intracerebral hemorrhage, but it is less important for subarachnoid hemorrhage (Bamford et al. 1990 Rothwell et al. 2005). Overall stroke incidence at age 75-84 is approximately 25 times higher than at age 45-54 (see Fig. 1.2). [Pg.16]

Factors associated with an increased risk ofvascuiar disease [Pg.17]

Evidence of pre-existing vascuiar disease Transient ischemic attacks Cervical arterial bruit and stenosis Myocardial infarction/angina [Pg.17]

There is a great deal of data concerning risk factors for VAP. These factors are important since they may contribute to the development of effective prevention programs by indicating which patients may be most likely to benefit from prophylaxis against pneumonia. We herewith discuss the most relevant risk factors for endogenous infection in VAP, although data on many of these factors continue to be controversial. These risk factors are listed in Table 1. [Pg.391]

The distribution of microorganisms, especially potentially resistant bacteria, differs with prior antibiotic therapy. Likewise, previous antibiotic administration may influence the development of VAP in two different ways its use may be associated with a protective effect against early-onset pneumonia, or it may be associated with an increased risk of late-onset [Pg.391]

Decrease in pressure of the tracheal tube cuff Stress-ulcers prophylaxys (anti-H2) Tracheostomy Coma and head trauma Nasogastric tube and gastric distension Patient transport [Pg.391]

The diagnostic tests performed on suspicion of VAP have two objectives. The first is to determine whether the patient really has an infectious pulmonary process as indicated by the signs and symptoms leading to the use of these tests. The second is the isolation of the causative microorganisms of the disease. [Pg.393]

Abbreviations. Pa02, oxygen arterial pressure FiOj, inspired fraction of oxygen ARDS, acute respiratory distress syndrome. [Pg.394]

Some patients first sign of morbidity from elevated lOP can be presentation with sudden loss of vision due to a central retinal vein occlusion (CRVO). Elevated lOP is the second most common risk factor for CRVO behind systemic hypertension. [Pg.416]

Cognitions are beliefs that contribute to drug use behavior. The following are important beliefs that have been associated with drug use  [Pg.28]

Common emotions associated with addictive processes include the following  [Pg.28]

Many chemically dependent clients have difficulties identifying and regulating their emotions, much to their detriment. [Pg.28]

Stability testing is a technical experiment conducted at well-defined conditions, for example at fixed temperatures and humidities. These testing conditions provide a model for the climatic conditions in the environment in which the drug substance or medicinal product is stored and shipped during shelf-life. This environment can be sufficiently described by parameters influencing the stability, mainly heat and [Pg.45]

There are, however, several other risk factors, which could have an impact on the stability of a drug substance or a drug product  [Pg.46]

In the following, only the external risk factors heat and moisture are evaluated. [Pg.46]


Type of pollutant Weight % of volatile organic compounds contained In exhaust gas Relative risk factor... [Pg.261]

Cholesterol is biosynthesized in the liver trans ported throughout the body to be used in a va riety of ways and returned to the liver where it serves as the biosynthetic precursor to other steroids But cholesterol is a lipid and isn t soluble in water How can it move through the blood if it doesn t dis solve in if The answer is that it doesn t dissolve but IS instead carried through the blood and tissues as part of a lipoprotein (lipid + protein = lipoprotein) The proteins that carry cholesterol from the liver are called low density lipoproteins or LDLs those that return it to the liver are the high-density lipoproteins or HDLs If too much cholesterol is being transported by LDL or too little by HDL the extra cholesterol builds up on the walls of the arteries caus mg atherosclerosis A thorough physical examination nowadays measures not only total cholesterol con centration but also the distribution between LDL and HDL cholesterol An elevated level of LDL cholesterol IS a risk factor for heart disease LDL cholesterol is bad cholesterol HDLs on the other hand remove excess cholesterol and are protective HDL cholesterol IS good cholesterol... [Pg.1096]

In 1986, the FDA s Sugars Task Force assessed the impact of sugar consumption on human health and nutrition and concluded that sucrose is not an independent risk factor for heart disease, nor does it cause or contribute to the development of diabetes (62). Although diet is important after the onset of diabetes, sucrose can be well tolerated by insulin-dependent diabetics (63—65). [Pg.6]

Homocysteine arises from dietary methionine. High levels of homocysteiae (hyperhomocysteinemia) are a risk factor for occlusive vascular diseases including atherosclerosis and thrombosis (81—84). In a controlled study, semm folate concentrations of <9.2 nmol/L were linked with elevated levels of plasma homocysteiae. Elevated homocysteine levels have beea associated also with ischemic stroke (9). The mechanism by which high levels of homocysteine produce vascular damage are, as of yet, aot completely uaderstood. lateractioa of homocysteiae with platelets or eadothehal cells has beea proposed as a possible mechanism. Clinically, homocysteine levels can be lowered by administration of vitamin B, vitamin B 2> foHc acid. [Pg.42]

Homocysteine has been identified as an independent risk factor for atherosclerosis (32) and thus metaboHc control over homocysteine levels has major health implications. [Pg.112]

Hypertension is one of the two principal risk factors of many cardiovascular diseases, such as coronary heart disease (CHD), stroke, and CHF. Individuals are considered hypertensive if their systoHc arterial blood pressure is over 140 mm Hg (18.7 Pa) or their diastoHc arterial blood pressure is over 90 mm Hg (12 Pa). Over 60 million people, or one-third of the adult population in the United States are estimated to be hypertensive (163). About 90% of these patients are classified as primary or essential hypertensive because the etiology of their hypertension is unknown. It is generally agreed that there is a very strong genetic or hereditary component to this disease. [Pg.132]

The fact that ceU culture-derived products are often injected into humans as therapeutic agents makes it imperative that there be no component in the final product that can pose a potential health risk to the patient. Health risks can be introduced into a product from many sources including the ceUs themselves raw materials, such as semm, media components, etc materials used in purification, eg, antibodies and external contamination. Eor a therapeutic product such risk factors are identified at the outset and ways of reducing them to acceptable levels are designed into the process. Before a product is released by the EDA the manufacturer has to demonstrate this risk reduction by rigorous validation of the process. [Pg.234]

Most of these methods are commonly employed in the downstream processing of the desired ceU culture technology product. Hence, most of the time it is only necessary to demonstrate that the designed process is reducing the putative risk factors to acceptable levels. Validation methods employed for risk reduction are discussed in the Hterature (25). [Pg.234]

The beneficial effects of dietary fiber, including both soluble and iasoluble fiber, are generally recognized. Current recommendations are for daily iatakes of 20—35 g ia a balanced diet of cereal products, fmits, vegetables, and legumes. However, the specific preventive role of dietary fiber ia certaia diseases has beea difficult to estabUsh, ia part because dietary risk factors such as high saturated fat and high proteia levels are reduced as fiber levels iacrease. [Pg.70]

Another study (84), which enrolled men and women between the ages of 21—55 who had mild hypertension and no recognizable cardiovascular risk factors, showed no significant differences in mortaUty between dmg- and placebo-treated patients. Significant reductions in hypertensive complications were noted, but atherosclerotic complications were not reduced. [Pg.212]

Breast Cancer. Many studies have observed low incidences of hormone-dependent cancers, particularly breast cancer, in Asian countries compared with Western countries and it is becoming increasingly accepted that dietary factors play an important role. Although breast cancer can occur in either males or females, only about 1 % of all cases occur in men, and male breast cancer is a rare disease in all parts of the world." Although there appear to be some similar risk factors for breast cancer in males and females, there is no indication in the literature that diet is either a risk or a protective factor for male breast cancer. The development of breast cancer is known to be highly dependent on the hormones associated with female reproductive functions, while established genetic factors have been... [Pg.116]

Several studies have investigated the role of dietary factors in prostate cancer risk, but results appear inconsistent. Significant effects have not been detected for dietary soya products certain vegetables, beans, fruit, rice and seaweed appear to be protective in some studies, while another has shown no protective effect from seaweed or vegetable consumption. In addition, a number of other risk factors have been shown to be associated with an increased risk of this cancer, including meat and dairy products and carotenoids. [Pg.122]

In adults, a few areas may require further study. For example, there is a report of soya consumption causing an increased incidence of hyperplastic epithelial cells in the nipple aspirate fluid of pre- and postmenopausal women.This could constitute a risk factor for breast cancer. Also, the use in herbal medicine of particular plants emphasises that these species have the potential to cause physiological changes. Consequently, the increasing public interest in the use of herbal medicines could lead to unintended (adverse) effects, particularly as most... [Pg.129]

Silverman, D. T., Levin, L. 1., Hoover, R. N., and Hartge, P. (1989). Occupational risk factors of bladder cancer in the United States I. White men. /. Natl. Cancer Inst. 81, 1472 -14SI, . Silverman, D. T, Levin, L. L, and Eloovet, R. N. (1990). Occupational risk factors of hladLler cancer among white women in the United States. Am. j. Epidemiol. 1.32, 453-461. [Pg.337]

Sicmiarycki, )., Dewar, R., Nadon, L.., and Gerin, M. (1994). Occupational risk factors for bladder cancer Results from a case-control study in Montreal, Quebec, Canada. Am. J. Epide-miol. 140, 1061-1080. [Pg.337]

Sieiniatycki, j. (Fcl.) (1991). Risk Factors for Cancer in the Workplace, CRC Press, Boca Raroii, FI,. [Pg.337]

Low-density lipoprotein (LDL) (Section 26.11) A protein which carries cholesterol from the liver through the blood to the tissues. Elevated LDL levels are a risk factor for heart disease LDL is often called bad cholesterol. ... [Pg.1288]


See other pages where Risks factors is mentioned: [Pg.17]    [Pg.245]    [Pg.31]    [Pg.250]    [Pg.41]    [Pg.430]    [Pg.177]    [Pg.215]    [Pg.132]    [Pg.212]    [Pg.87]    [Pg.87]    [Pg.88]    [Pg.93]    [Pg.117]    [Pg.123]    [Pg.124]    [Pg.128]    [Pg.338]    [Pg.196]    [Pg.405]    [Pg.482]    [Pg.359]    [Pg.248]    [Pg.337]    [Pg.933]    [Pg.325]    [Pg.325]    [Pg.585]    [Pg.178]    [Pg.1017]    [Pg.1017]    [Pg.66]   
See also in sourсe #XX -- [ Pg.321 ]

See also in sourсe #XX -- [ Pg.258 ]

See also in sourсe #XX -- [ Pg.267 ]

See also in sourсe #XX -- [ Pg.85 ]

See also in sourсe #XX -- [ Pg.108 , Pg.120 ]

See also in sourсe #XX -- [ Pg.78 ]

See also in sourсe #XX -- [ Pg.65 ]

See also in sourсe #XX -- [ Pg.314 ]

See also in sourсe #XX -- [ Pg.37 , Pg.37 , Pg.38 , Pg.38 , Pg.137 , Pg.150 ]

See also in sourсe #XX -- [ Pg.729 , Pg.732 ]

See also in sourсe #XX -- [ Pg.26 , Pg.27 , Pg.30 , Pg.32 , Pg.37 , Pg.38 , Pg.51 , Pg.129 , Pg.215 , Pg.259 , Pg.286 ]

See also in sourсe #XX -- [ Pg.4 , Pg.37 , Pg.110 , Pg.112 , Pg.115 , Pg.116 , Pg.122 ]

See also in sourсe #XX -- [ Pg.392 , Pg.404 , Pg.423 , Pg.433 ]

See also in sourсe #XX -- [ Pg.49 , Pg.66 ]

See also in sourсe #XX -- [ Pg.219 ]

See also in sourсe #XX -- [ Pg.207 ]

See also in sourсe #XX -- [ Pg.45 , Pg.54 , Pg.192 , Pg.193 ]

See also in sourсe #XX -- [ Pg.405 ]

See also in sourсe #XX -- [ Pg.460 , Pg.993 ]




SEARCH



ARM model risk factors

Acute kidney injury risk factors

Adverse drug reactions risk factors

Aggression risk factors

Alcohol cancer risk factor

Alzheimer genetic risk factors

Alzheimer’s disease risk factors

Amphotericin risk factors

Angina risk factors

Application of the Modifying Factor in Risk Index

Associated Risk Factors

Asthma risk factors

Atherogenic risk factor

Atherosclerosis risk factor modification

Atherosclerosis risk factors

BASF risk factors

Behavioral Risk Factor Surveillance System

Biological risk factors

Cancer risk factors

Cancer risk factors, carcinogens

Cancer risk factors, evaluating

Carcinogenic risk, influencing factors

Cardiac risk factors

Cardiovascular disease risk factors

Cardiovascular risk factors

Cerebrovascular disorders risk factors

Children risk factors

Cholesterol cancer risk factor

Chronic obstructive pulmonary disease risk factors

Chronic rejection risk factors

Coenzyme risk factors

Cognitive decline risk factors

Cognitive risk factors

Colitis, risk factor

Colorectal cancer clinical risk factors

Constipation risk factors

Contact dermatitis risk factor

Contrast-induced nephropathy risk factors

Coronary artery disease risk factors

Corticosteroids risk factors

Cross-reactions risk factor

Cuts, risk factor

DRESS risk factors

Dementia risk factors

Dependence risk factors

Depressive disorders risk factors

Device-associated risk factors

Diabetes mellitus type risk factors

Diabetes mellitus, risk factor

Diabetic nephropathy risk factors

Drug allergy risk factors

Duodenal ulcer risk factors

Economic risk factor

Eczema risk factor

Emotional risk factors

Endometrial risk factors

Enteral feeding risk factor

Environmental risk factors

Erectile dysfunction risk factors

Ergonomic Risk Factors

Escherichia coli risk factors

Esophageal cancer risk factors

Extrapolation factors, risk assessment

Extrinsic risk factors

FACTORS INFLUENCING RISK PERCEPTION

Factors Which Influence the Degree of Clinical Risk

Factors affecting health risk

Falls risk factors

Fatty acids cancer risk factor

Folate deficiency risk factors

Gallbladder cancer risk factors

Gastric cancer risk factors

Genetic risk factors

Glaucoma risk factors

Global Risk Factors

Hand risk factors

Hazards ergonomic risk factors

Heart attacks risk factors

Hepatitis risk factors for acquiring

Hypersensitivities risk factor

Hypertension risk factors

INDEX risk factors for

Insomnia risk factors

Integrated systems risk factors

Intrinsic risk factors

Irritant risk factors

Key Factors for a Successful Risk Analysis

Key Factors to Consider in Process Plant Building Risk Assessments

Kuopio ischemic heart disease risk factor

Lifestyle risk factors

Lipids risk factors

Liver disease risk factors

MRFIT (Multiple Risk Factor

Metabolic Syndrome risk factors

Modifying factor Risk index

Multiple Risk Factor Intervention

Multiple Risk Factor Intervention Trial

Myocardial infarction risk factors

Nebulizers risk factor

Needs assessment risk factors

Neural tube defects genetic risk factors

Nosocomial respiratory infections risk factors

OTHER CARDIAC RISK FACTORS

Obesity risk factors

Operational risk factor

Osteoarthritis risk factors

Osteoporosis risk factors

Pancreatic cancer risk factors

Patients host-associated risk factors

Pentamidine risk factors

Pernicious anaemia risk factors

Pneumonia risk factors

Pollution cancer risk factor

Polymorphisms disease, risk factors

Polypharmacy risk factors

Postoperative pneumonia risk factors

Pregnancy risk factor

Prevalence and Risk Factors

Production environment: risk factors

Proteins cancer risk factor

Psoriasis, risk factor

Quantitative risk analysis influencing factors

Radiation therapy, risk factor

Renal failure, acute risk factors

Risk Analysis and Human Factors Engineering

Risk Assessment scaling factors

Risk Factors for Adverse Drug Events

Risk Factors for Chronic Rejection

Risk Factors for Dementia

Risk Factors for Drug Allergy

Risk Factors for Dryness of the Mouth

Risk Factors for Immediate (Type I) Reactions to Penicillins

Risk and protective factors

Risk assessment default factors

Risk assessment factors

Risk assessment factors, California

Risk assessment human factor

Risk assessment protective factors

Risk assessment public decision factors

Risk assessment relative potency factor

Risk assessment safety factors

Risk assessment uncertainty factor

Risk assessment, influencing factors

Risk factors and management

Risk factors anorexia nervosa

Risk factors behavioral

Risk factors breast cancer

Risk factors colon cancer

Risk factors community issues

Risk factors dietary

Risk factors for TIA and

Risk factors for TIA and stroke

Risk factors for drug misus

Risk factors groundwater

Risk factors host-associated

Risk factors level

Risk factors medical patients

Risk factors research needs

Risk factors surface water

Risk factors surgical patients

Risk factors thrombosis

Risk factors, cancer, animal studie

Risk factors, coronary heart disease

Risk factors, medical

Risk factors, mitigation

Risk factors, workplaces

Risk factors, workplaces assessment factor

Risk management social factors

Risk reduction factor

Risk sources lifestyle factors

Risks tissue metabolic activity, factors

Safety considerations risk factors

Schizophrenia risk factors

Self-harm risk factors

Self-harm suicide risk factors

Some Risk Factors in Processes and Projects

Spirometry risk factor

Stability testing risk factors

Stress risk factor

Stroke risk factors

Stroke risk factors for

Tetanus risk factors

Toxicity chronic, risk factors

Tumor necrosis factor antagonists, infection risk

Ulcerative colitis risk factors

Vascular risk factors

Vascular risk factors stroke

Ventilator-associated pneumonia risk factors

Workplace hazards risk factors

© 2024 chempedia.info